This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
For now, though, many challenges remain, and few AI tools have been proven to improve care, according to a new American Heart Association scientific statement published today in Circulation , the Association’s flagship, peer-reviewed journal.
Findings of a review of data from three clinical trials challenge current bestpractice for use of the drug for primary prevention of heartdisease or stroke -- otherwise known as atherosclerotic cardiovascular disease.
In these panel discussions, host Andrea Price MS, AACC brings together Kim Guibone, DNP, ACNP-BC, FACC, Susan Schnell, ACNP and Bailey Estes MSN, AGNP-C, to explore bestpractices related to structural heartdisease.
In this panel discussion, host Andrea Price MS, AACC brings together Tricia Keegan, NP, DNP, FACC, Disty Pearson, PA-C, AACC, and Bailey Estes MSN, AGNP-C, to explore bestpractices related to structural heartdisease. In this episode, the focus is on congenital heartdisease.
Over the past decade, new research has advanced scientific knowledge of neurodevelopmental trajectories, factors that increase neurodevelopmental risk, and neuroprotective strategies for individuals with congenital heartdisease. It also includes an updated algorithm for referral, evaluation, and management of individuals at high risk.
Last, a key objective of this scientific statement is to further the field by identifying bestpractices, gaps, and challenges for interested stakeholders.
In this panel discussion, host Andrea Price MS, AACC brings together Martina Speight FNP-BC, MS, Jane Linderbaum ARNP, CNP, FACC and Bailey Estes MSN, AGNP-C to explore bestpractices related to structural heartdisease.
In these panel discussions, host Andrea Price MS, AACC brings together Bailey Estes MSN, AGNP-C, Nicole Dellise, NP, and Kristen deAlmeida, PharmD to explore bestpractices related to structural heartdisease. In this episode, the focus is on mitral valve disease.
In this panel discussion, host Andrea Price MS, AACC brings together Liz Perpetua ARNP, ACNP-BC, DNP, FACC, Martha Gulati MD, MS, FACC, and Bailey Estes MSN, AGNP-C, to explore bestpractices related to structural heartdisease. In this episode, the focus is on shared decision making.
This episode is an update to the March 2024 PulseCheck: Shared Decision Making podcast in which host Andrea Price MS, AACC brings together Liz Perpetua ARNP, ACNP-BC, DNP, FACC, Martha Gulati MD, MS, FACC, and Bailey Estes MSN, AGNP-C, to explore bestpractices related to structural heartdisease.
In these panel discussions, host Andrea Price, MS, AACC brings together Marian Hawkey, RN and Misty Theriot, BSN to explore bestpractices related to structural heartdisease.
In this panel discussion, host Andrea Price MS, AACC brings together Gigi Wyman, DNP, RNCS FACC and Wayne Batchelor, MD, FACC and Bailey Estes MSN, AGNP-C, to explore bestpractices related to structural heartdisease.
In this panel discussion, host Andrea Price MS, AACC brings together Marcus Burns, DNP, Kristen deAlmeida, PharmD, and Bailey Estes MSN, AGNP-C, to explore bestpractices related to structural heartdisease. In this episode, the focus is on tricuspid valve disease.
n this panel discussion, host Andrea Price MS, AACC brings together Holly Dalton, MSN, Joan Michaels, RN, AACC, and Bailey Estes MSN, AGNP-C, to explore bestpractices related to structural heartdisease. In this episode, the focus is on quality in structural heart.
In this panel discussion, host Andrea Price MS, AACC brings together Jasmina Katinic ARNP, AACC, Nicole Jones ACNS-BC, CCNS, CHFN, AACC, and Bailey Estes MSN, AGNP-C, to explore bestpractices related to structural heartdisease. In this episode, the focus is on left atrial appendage closure.
Webinar STS South Asia Webinar in collaboration with IACTS : Rheumatic Mitral Valve Repair gmckinney Fri, 10/18/2024 - 10:43 November 9, 2024 The first session of the South Asia webinar series delves into valve repair strategies for rheumatic mitral valve disease.
Webinar Rheumatic Mitral Valve Repair: STS South Asia Webinar in collaboration with IACTS gmckinney Fri, 10/18/2024 - 10:43 November 9, 2024 The first session of the South Asia webinar series delves into valve repair strategies for rheumatic mitral valve disease.
Last year, I asked whether you would be interested in a course that would help you prevent heartdisease. The course is a product of over a decade's worth of research on the best approaches to preventing heartdisease, with the biggest emphasis being on lifestyle measures. Define your risk of heartdisease.
Within the complex umbrella of cardiovascular disease, CAD is a type of heartdisease that develops when the coronary arteries narrow and the heart cannot deliver enough oxygen-rich blood to the heart.
This July, thousands of you said that you wanted me to produce a course that would synthesise bestpractices for: Understanding heartdisease. Are frustrated with the standard model of healthcare that seems to only react when you have progressed to the point of having serious heartdisease. if required.
For nearly two decades, CRF has led the way in pioneering transcatheter therapies for structural heartdisease at TVT. New York Valves marks the next iteration of this legacy, featuring three days of transformative research and techniques that will redefine the landscape of structural heart interventions.
For nearly two decades, CRF has led the way in pioneering transcatheter therapies for structural heartdisease at TVT. New York Valves marks the next iteration of this legacy, featuring three days of transformative research and techniques that will redefine the landscape of structural heart interventions.
Contractions of the heart muscle are caused by electrical impulses, which, when recorded on a graph, form an electrocardiogram. Accurate ECG readings are crucial for proper diagnosis of heartdiseases and monitoring of patients.
This 3-day event will bring together a world-class, international faculty to explore the latest developments and bestpractices in coronary artery disease, congenital heartdisease, thoracic aortic disease, atrial fibrillation, and the surgical management of heart failure.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content